CORNEA_PROTECT®

Article

CORNEA_PROTECT® (2% HPMC) guarantees protection and moisturization of the corneal surface during surgical procedures for up to 20 min. Also applications as a contact agent are possible.

CORNEA_PROTECT® (2% HPMC) guarantees protection and moisturization of the corneal surface during surgical procedures for up to 20 min. Also applications as a contact agent are possible.

CORNEA_PROTECT® (2% HPMC) is a lubricant and contact agent for the protection of the corneal surface during surgical procedures. Exclusively developed and manufactured by CROMA, CORNEA_PROTECT®; guarantees a perfect protection of the corneal epithelium from drying out and an excellent optical clarity during the surgery.CORNEA_PROTECT® is adapted for both anterior segment procedures as well as for vitreo-retinal surgery involving contact lenses or three mirror lenses. Thanks to its long retention time on the corneal surface each application will assure the protection of the cornea for up to 20 minutes. Each unit dose (2 mL) allows repeated applications during the same surgical procedure. The product is ready-to-use in the operating theatre.

www.croma.atoffice@croma.at

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.